Filing Details
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 12, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:UNCY
Unicycive Therapeutics, Inc. (UNCY) Files Quarterly Report for Q0
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 12, 2026.
At publication ·
What changed
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Unicycive Therapeutics, Inc. (NASDAQ: UNCY) filed its quarterly report (Form 10-Q) with the SEC on August 12, 2026.
- The company's stock trades at $5.39 with a market capitalization of $113.3 million.
- The 10-Q filing contains unaudited financial statements and management commentary on recent performance, including updated risk factors and changes in business conditions.
Market Context
Unicycive Therapeutics, Inc.'s stock currently trades at $5.39 with a market capitalization of $113.3M.
The 10-Q provides Unicycive Therapeutics, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Unicycive Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View UNCY Stock Page
Frequently Asked Questions
Where can I read UNCY's SEC filings?
Browse all filings on our UNCY SEC filings page.
What types of SEC filings does Unicycive Therapeutics, Inc. file?
Public companies like Unicycive Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.